Advertisement

Topics

Tandem Diabetes Care Begins Enrollment in Pivotal Trial for First Touchscreen Insulin Pump with PLGS

14:00 EDT 18 Aug 2017 | Drug Discovery Development

The primary endpoint of the study is to demonstrate a reduction in the percentage of CGM values below 70 mg/dL when using Tandem’s PLGS algorithm.
Contributed Author: 
Tandem
Topics: 

Original Article: Tandem Diabetes Care Begins Enrollment in Pivotal Trial for First Touchscreen Insulin Pump with PLGS

NEXT ARTICLE

More From BioPortfolio on "Tandem Diabetes Care Begins Enrollment in Pivotal Trial for First Touchscreen Insulin Pump with PLGS"

Advertisement
Quick Search
Advertisement
Advertisement